User:Mr. Ibrahem/Odevixibat

Odevixibat, sold under the trade name Bylvay, is a medication used to treat itchiness in progressive familial intrahepatic cholestasis (PFIC). It is used in those who are at least 3 months old. It is taken by mouth.

Common side effects include diarrhea, abdominal pain, liver enlargement, fat-soluble vitamin deficiency, and liver inflammation. Safety in pregnancy is unclear, with some evidence of harm. It is a inhibitor of the ileal bile acid transporter (IBAT).

Odevixibat was approved for medical use in the United States and Europe in 2021. In the United Kingdom a month of medication at a dose of 400 mcg is about £6,200 as of 2022. This amount in the United States is about 13,000 USD.